Insights

Global Expansion Orphazyme is rapidly growing with global offices in Denmark, Switzerland, and the US, offering potential sales opportunities in multiple regions.

Recent Partnerships Orphazyme's recent partnerships and asset sales to companies like KemPharm present opportunities for collaboration and potential sales synergies.

Leadership Changes The appointment of Anders Vadsholt as CEO brings fresh leadership to Orphazyme, potentially signaling new strategic directions and sales initiatives.

Public Offering Success Orphazyme's successful IPO in September 2020 showcases investor confidence, potentially opening doors for sales growth and market expansion.

Specialized Therapies With a focus on innovative treatments for neurodegenerative diseases, Orphazyme's specialized expertise presents unique sales opportunities in niche markets.

Orphazyme A/S Tech Stack

Orphazyme A/S uses 8 technology products and services including MooTools, jQuery UI, jQuery, and more. Explore Orphazyme A/S's tech stack below.

  • MooTools
    Javascript Frameworks
  • jQuery UI
    Javascript Libraries
  • jQuery
    Javascript Libraries
  • Underscore.js
    Javascript Libraries
  • WP Engine
    Platform As A Service
  • Yoast SEO
    Search Engines
  • Adobe Tag Manager
    Tag Management
  • Twitter
    Widgets

Media & News

Orphazyme A/S's Email Address Formats

Orphazyme A/S uses at least 1 format(s):
Orphazyme A/S Email FormatsExamplePercentage
First.Last@orphazyme.comJohn.Doe@orphazyme.com
45%
Last@orphazyme.comDoe@orphazyme.com
5%
First.Last@orphazyme.comJohn.Doe@orphazyme.com
45%
Last@orphazyme.comDoe@orphazyme.com
5%

Frequently Asked Questions

Where is Orphazyme A/S's headquarters located?

Minus sign iconPlus sign icon
Orphazyme A/S's main headquarters is located at DK. The company has employees across 3 continents, including EuropeNorth AmericaAfrica.

What is Orphazyme A/S's phone number?

Minus sign iconPlus sign icon
You can contact Orphazyme A/S's main corporate office by phone at . For more prospecting data, LeadIQ has access to up-to-date and accurate contact information within our platform. Find, capture, and sync contact data to your CRM and sales tools in one click.

What is Orphazyme A/S's stock symbol?

Minus sign iconPlus sign icon
Orphazyme A/S is a publicly traded company; the company's stock symbol is ORPHY.

What is Orphazyme A/S's official website and social media links?

Minus sign iconPlus sign icon
Orphazyme A/S's official website is orphazyme.com and has social profiles on LinkedIn.

What is Orphazyme A/S's SIC code NAICS code?

Minus sign iconPlus sign icon
Orphazyme A/S's SIC code is 8733 - Noncommercial Research Organizations NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does Orphazyme A/S have currently?

Minus sign iconPlus sign icon
As of December 2021, Orphazyme A/S has approximately 108 employees across 3 continents, including EuropeNorth AmericaAfrica. Key team members include Chief Commercial Officer And Us President: P. M.Head Of Global Product Strategy: A. H.Director - National Accounts: J. M.. Explore Orphazyme A/S's employee directory with LeadIQ.

What industry does Orphazyme A/S belong to?

Minus sign iconPlus sign icon
Orphazyme A/S operates in the Biotechnology Research industry.

What technology does Orphazyme A/S use?

Minus sign iconPlus sign icon
Orphazyme A/S's tech stack includes MooToolsjQuery UIjQueryUnderscore.jsWP EngineYoast SEOAdobe Tag ManagerTwitter.

What is Orphazyme A/S's email format?

Minus sign iconPlus sign icon
Orphazyme A/S's email format typically follows the pattern of . Find more Orphazyme A/S email formats with LeadIQ.

How much funding has Orphazyme A/S raised to date?

Minus sign iconPlus sign icon
As of December 2021, Orphazyme A/S has raised $109M in funding. The last funding round occurred on Feb 07, 2020 for $109M.

When was Orphazyme A/S founded?

Minus sign iconPlus sign icon
Orphazyme A/S was founded in 2009.
Orphazyme A/S

Orphazyme A/S

Biotechnology ResearchDenmark51-200 Employees

Orphazyme is a global biopharmaceutical company, headquartered in Denmark, with a rapidly growing presence in the United States. We are pioneering a new kind of treatment, applying our specialized expertise to bring innovative therapies to patients with neurodegenerative orphan diseases. With a late-stage drug pipeline, we are relentless in our commitment to advancing treatments and making a profound impact for those touched by these rare, serious diseases.

Today we are listed on Nasdaq Copenhagen (TICKER: ORPHA.CO) and Nasdaq U.S. (TICKER: ORPH), and are expanding our global presence with offices in Denmark, Switzerland, and our US headquarters in Chicago.

See our community guidelines: bit.ly/3uapRYr

Section iconCompany Overview

Headquarters
DK
Phone number
SIC Code
8733 - Noncommercial Research Organizations
Stock Symbol
ORPHY
NAICS Code
541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Founded
2009
Employees
51-200

Section iconFunding & Financials

  • $109M

    Orphazyme A/S has raised a total of $109M of funding over 7 rounds. Their latest funding round was raised on Feb 07, 2020 in the amount of $109M.

Section iconFunding & Financials

  • $109M

    Orphazyme A/S has raised a total of $109M of funding over 7 rounds. Their latest funding round was raised on Feb 07, 2020 in the amount of $109M.

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.